Voyageur Pharmaceuticals Ltd.
VYYRF
$0.13
$0.0218.90%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.32% | -62.45% | -57.66% | -21.15% | 10.18% |
| Total Depreciation and Amortization | -30.77% | -28.57% | -26.67% | -25.00% | -79.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.43% | 102.16% | 97.56% | 78.18% | 35.62% |
| Change in Net Operating Assets | -139.60% | -130.44% | -107.01% | 738.83% | 748.16% |
| Cash from Operations | -713.99% | -248.54% | -95.64% | 74.44% | 76.41% |
| Capital Expenditure | -27.74% | 9.23% | 2.29% | 6.02% | 13.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.74% | 9.23% | 2.29% | 6.02% | 9.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 567.63% | 234.63% | 216.94% | -58.96% | -58.96% |
| Repurchase of Common Stock | -- | -- | 65.85% | 65.85% | -123.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,007.96% | 1,245.67% | 1,669.17% | 238.27% | 54.49% |
| Cash from Financing | 660.99% | 313.80% | 303.04% | -48.88% | -60.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19,761.76% | 416.69% | 190.42% | 683.65% | 101.76% |